Screening, Brief Intervention, and Referral to Treatment (SBIRT)
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive public health approach for delivering early intervention and treatment services to people with, or at risk of developing substance use disorders.
Screening: Screening is a way to identify patients with risky substance use patterns. It does not establish definitive information about diagnosis and possible treatment needs. The goal of SBIRT is to make screening for risky substance use a routine part of medical care to help identify those who may not seek help on their own.
Brief Intervention: Brief intervention is a single session or multiple sessions of motivational discussion focused on increasing the patient’s insight and awareness regarding substance use and his or her motivation toward behavioral change. Brief intervention can be tailored for variance in population or setting and can be used as a stand-alone intervention for risky substance users as well as a vehicle for engaging those in need of more extensive levels of care.
Referral to Treatment: Referral to specialized treatment is provided to those identified as needing more extensive treatment than offered by the SBIRT program. The effectiveness of the referral process to specialty addictions treatment is a strong measure of SBIRT success and involves a proactive and collaborative effort between SBIRT providers and those providing treatment to ensure access to the appropriate level of care.
Dentists, Doctors, First Responders, Medical Staff, Nurses, Social Workers
Recognize neuroanatomy and neuropathology of pain and addiction on the human body.
Identify non-opioid pain treatment options.
Describe theories of addiction treatment.
Articulate respectful communication with patients and health professionals when discussing substance use.
Simulate communication skills in using SBIRT (screening, brief intervention, and referral to treatment) to partner with patients who are using substances in a risky or unhealthy manner.
Demonstrate appropriate hand-off communication when referring a patient for further treatment related to risky or unhealthy substance use of substance use disorder.
REBECA WILSON, PhD, RN
MELISSA CHENG, MD, MPH
GLEN HANSON, DDS, PhD
KATHERINE FORTENBERRY, PhD
None of the speakers or planners or anyone in control of content for this accredited continuing educational activity have any relevant financial relationships since the content does not relate to any products or services of an ACCME-defined ineligible company; therefore, there are no relevant financial relationships to disclose or mitigate.
A certificate of participation will be provided upon successful completion of the course.
- Certificate of Participation provided for insurance billing purposes
- Satisfies requirements for HB 175 from the 2017 legislative session
If you are a controlled substance prescriber, you will need to claim CME credit to receive the DOPL required documentation of completion.
To obtain additional information related to CME requirements outlined in HB 175 click here.
To receive CME for this course, you will need to pay a $50 fee. A link to pay for the CME certificate will be provided in the course.
The University of Utah School of Medicine designates this enduring material for a maximum of 3.50 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NONDISCRIMINATION AND DISABILITY ACCOMMODATION STATEMENT:
The University of Utah does not discriminate on the basis of race, color, national origin, sex, disability
METHOD OF PARTICIPATION:
To receive a statement of credit, you must:
- Watch the videos in their entirety
- Successfully complete the post-tests (80%)
Your statement of credit will be recorded with the U of U CME office upon successful completion of the post-assessment, payment and submission of the evaluation.
- 3.50 AMA PRA Category 1 Credit™
This course is offered through Substance Education Institute.
To take this course you will be redirected to Substance Education Institute's website. You must login or create an account with Substance Education Institute in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!